Contact Person : Ms. Lincy; Last Date for the submission of abstract : 20/07/2012; Description : Biosimilars-2012 is designed to discuss the development and progress of research in the areas of drug discovery, clinical trials, regulatory and economic considerations towards Biosimilars and waiver for Bioequivalence studies.